EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Eli Lilly and Company (LLY) had EBIT Margin of 28.64% for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
$45.04B |
|
$10.59B |
|
$8.42B |
|
$36.62B |
|
$32.14B |
|
$12.90B |
|
$-218.60M |
|
$12.68B |
|
$12.68B |
|
$10.59B |
|
$10.59B |
|
$10.59B |
|
$10.59B |
|
$12.90B |
|
$14.67B |
|
900.61M |
|
904.06M |
|
$11.76 |
|
$11.71 |
|
Balance Sheet Financials | |
$32.74B |
|
$17.10B |
|
$45.98B |
|
$78.71B |
|
$28.38B |
|
$28.53B |
|
$36.07B |
|
$64.44B |
|
$14.27B |
|
$2.33B |
|
$14.27B |
|
947.54M |
|
Cash Flow Statement Financials | |
$8.82B |
|
$-9.30B |
|
$1.23B |
|
$2.82B |
|
$3.27B |
|
$449.80M |
|
$645.60M |
|
$-4.68B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.15 |
|
-- |
|
-- |
|
0.67 |
|
2.36 |
|
81.31% |
|
28.64% |
|
EBIT Margin |
28.64% |
32.56% |
|
28.15% |
|
23.51% |
|
$3.76B |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
1.11 |
|
3.39 |
|
107.58 |
|
74.20% |
|
453.53% |
|
13.45% |
|
24.74% |
|
$15.06 |
|
$4.16 |
|
$9.75 |